Comprehensive analysis of E2F-1 as a proliferative marker in breast cancer, exploring its role in cell cycle regulation and clinical significance.
Discover how BRD7, once a prime suspect in breast cancer genetics, was cleared through large-scale genetic studies, advancing our understanding of cancer risk factors.
Explore how palbociclib, the first CDK4/6 inhibitor, is transforming treatment for hormone receptor-positive breast cancer through precision targeting of the cell cycle.
Discover how BRCA research using next-generation sequencing is transforming breast cancer detection and prevention in Kurdish women through population-specific genetic studies.
Discover how superparamagnetic nanoparticles are revolutionizing breast cancer treatment by delivering drugs directly to cancer cells while minimizing side effects.
Exploring how PLGA-β-CD nanoparticles loaded with Methotrexate offer targeted breast cancer treatment with reduced side effects.
Discover how neratinib, a second-generation targeted therapy, is proving effective against HER2-mutant breast cancers, offering new hope where traditional treatments sometimes fail.
Discover how Phyllanthus niruri extract demonstrates dual protective and antitumor effects in DMBA-induced breast cancer models in irradiated rats.
Explore how nanotechnology-based electrochemical biosensors are transforming breast cancer detection through enhanced sensitivity, speed, and accuracy in biomarker monitoring.
Explore innovative strategies for safe fertility preservation in breast cancer patients through controlled ovarian stimulation protocols and estrogen-suppressing medications.